Laxmi Yeruva, PhD (she/her/hers)

USDA-ARS Research Leader
Microbiome and Metabolism Research Unit, USDA-ARS
Little Rock, Arkansas, United States

Dr. Laxmi Yeruva is a Research Leader of Microbiome and Metabolism Research Unit, USDA-ARS which is co-located with Arkansas Children’s Nutrition Center. She studies how prenatal and postnatal factors play a role on child health and development with emphasis on the gastrointestinal tract, microbiota, brain, and immune system. Her research has been supported by federal agencies (USDA-ARS, NIH) and private industries. She serves on journal editorial boards, grant panels (i.e., NIH study and various international agencies), organizes conferences and mentor’s junior investigators, students, and postdoctoral fellows. Her passion is to benefit the community through scientific solutions and evidence-based results.

Presentation(s):

• (PTFS05-02-24) Single-Cell RNA Sequencing Reveals That Breastfeeding Shapes IL-4 and IL-13 Signaling in Neonatal Peripheral Blood Mononuclear Cells

  Sunday, June 30, 2024
  10:04 AM – 10:08 AM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• (OR19-06-24) Apiaceous Vegetables Improved Gut Dysbiosis Induced by Dextran Sodium Sulfate in Mice Consuming Total Western Diet

  Monday, July 1, 2024
  9:00 AM – 9:12 AM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• The Arkansas Children’s Nutrition Research Center: 30 Years of Advancing Nutrition Science Research for Maternal and Child Health

  Tuesday, July 2, 2024
  8:00 AM – 9:30 AM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• Microbiome and Metabolism Research Unit: Bench to Community

  Tuesday, July 2, 2024
  9:10 AM – 9:30 AM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

• (PTFS21-02-24) Human Milk Oligosaccharides and Bifidobacteria Infantis Interactively Shape Mouse Splenic Immune Responses

  Tuesday, July 2, 2024
  8:04 AM – 8:08 AM CT

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.